Charles & Colvard (CTHR) Q4 2024 earnings summary

Executive summary

• Net sales declined 27% year-over-year to $22.0 million, with losses of $14.4 million and negative cash flow from operations of $7.4 million for the year ended June 30, 2024.

• The company faces substantial doubt about its ability to continue as a going concern due to recurring losses, negative cash flows, and a $4.8 million settlement related to the Wolfspeed arbitration.

• Strategic actions included cost reductions, supply chain consolidation, and a 1-for-10 reverse stock split to regain Nasdaq compliance.

• The company continues to focus on e-commerce, product innovation, and expanding its lab-grown diamond and moissanite jewelry offerings.

Financial highlights

• Net sales: $21.96 million in FY2024 vs. $29.95 million in FY2023, a 27% decrease.

• Net loss: $14.36 million in FY2024 vs. $19.58 million in FY2023.

• Gross margin: Product line gross profit was $10.1 million in FY2024, down from $14.8 million in FY2023.

• Finished jewelry accounted for 92% of sales; loose jewels 8%.

• Cash and cash equivalents at year-end: $4.1 million, with $2.3 million in short-term debt.

Outlook and guidance

• Management is focused on stabilizing operations, disciplined spending, and cost management to address liquidity challenges.

• The company is evaluating financing options, cost-saving actions, and potential inventory liquidation to fund operations.

• Strategic priorities include operational efficiency, product differentiation, and expanding direct-to-consumer channels.